Michael E. Maselli

FDA investigator

Appears on 6 documents from 2015 to 2023, most often at sites in Colorado. Most often cites control of microbiological contamination (21 CFR 211.113).

6
Documents on file
6.0
Observations per 483
2015
First seen
2023
Most recent

What they cite most

From 30 observations

Activity by year

2015: 1, 2016: 3, 2023: 2

Where

Colorado 2 · Japan 2 · France 1 · Illinois 1

Is Michael E. Maselli coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Rohto Pharmaceutical Co., Ltd.Mar 8, 2023 · Iga, Japan
483 TOYOBO CO., LTD.Feb 25, 2023 · Otsu, Japan
Response Pencol Compounding PharmacySep 12, 2016 · Denver, Colorado
483 Sage Products Inc 'Sep 1, 2016 · Cary, Illinois
483 Maplerose EntL-rprisej; LLC dba Pencol PhanuacyAug 8, 2016 · Denver, Colorado
483 Astrea MontsJun 9, 2015 · Monts, France

About this profile

What does Michael E. Maselli inspect?

Michael E. Maselli appears on 6 documents on file covering 5 sites, most often in Colorado.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.100 and 21 CFR 211.165.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michael E. Maselli is dated Mar 8, 2023.